Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats

Citation
Sj. Orange et al., Cardiovascular effects of chronic nitric oxide synthase inhibition in genetically hypertensive rats, CLIN EXP PH, 27(7), 2000, pp. 488-493
Citations number
36
Categorie Soggetti
Pharmacology & Toxicology
Journal title
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
ISSN journal
03051870 → ACNP
Volume
27
Issue
7
Year of publication
2000
Pages
488 - 493
Database
ISI
SICI code
0305-1870(200007)27:7<488:CEOCNO>2.0.ZU;2-H
Abstract
1. The possible role of an endothelial defect in the hypertension of the Ne w Zealand genetically hypertensive (GH) rat strain was assessed by examinin g cardiovascular responses to the nitric oxide synthase (NOS) inhibitor N-o mega-nitro-L-arginine methyl ester (L-NAME) and the endothelium-dependent d epressor agent acetylcholine (ACh). The vascular sensitivity of the hindqua rter to nitric oxide (NO) was examined using the NO donor sodium nitropruss ide (SNP). 2. N-G-Nitro-L-arginine methyl ester (10 mg/kg per day in drinking water) w as given to GH and normotensive (N) rats from age 7-9 weeks, with GH and N untreated control groups. Systolic blood pressure (tail-cuff) was monitored weekly from age 5-9 weeks. At age 9 weeks, pressure responses to various v asoactive agents were measured in vivo and in the rat isolated hindquarter. Left ventricular (LV) mass was measured at the time of death. 3. N-G-Nitro-L-arginine methyl ester induced a greater hypertensive effect in GH (P < 0.001) compared with N (P < 0.05) rats and caused a significant increase in hindquarter perfusion pressure in GH rats only (P < 0.01). 4. Genetically hypertensive rats had LV hypertrophy that was exacerbated by L-NAME (P < 0.01). Left ventricular hypertrophy was not induced by L-NAME in N rats. 5. The normalized response to ACh did not differ between GH and N control r ats and was unaffected by L-NAME treatment in vivo and in vitro except at t he highest ACh dose (3 mu g/kg) in GH hindquarters (P < 0.01). The response to SNP was similar in GH and N hindquarters and enhanced by L-NAME in GH ( 0.1 mu g; P < 0.05) and N rats (0.01 mu g, P < 0.01; 0.1 mu g, P < 0.001). 6. These results suggest that the L-arginine/NO system is not deficient in GH rats and that endothelial function in the GH hindquarter is preserved. T hey confirm that NO is involved in mediating blood pressure in GH and N rat s and raise the possibility that a non-NO-mediated mechanism may underlie A Ch-induced vasodilation in GH and N.